Table 1

Basic characteristics of the patients and baseline data (intention to treat)

Escin 1% (n=54)Escin 2% (n=51)Placebo (n=51)
*Injured/contralateral; †multiple citations possible.
SD, Standard deviation; Q1, lower quartile; Q3, upper quartile.
Sex
    Male, n (%)37 (68.5)34 (66.7)41 (80.4)
    Female, n (%)17 (31.5)17 (33.3)10 (19.6)
Age (years)
    Mean (median)29.2 (27)31.3 (30)30.7 (29)
    SD10.109.929.07
    Q1; Q322; 3324; 3524; 37
Height (cm)
    Mean (median)175.9 (175.5)176.6 (176)178.8 (179)
    SD10.2710.458.21
    Q1; Q3169; 182170; 185173; 185
Weight (kg)
    Mean (median)71.8 (72)73.7 (73)77.5 (77)
    SD12.3013.9710.45
    Q1; Q363; 8265; 8372; 84
Tenderness injured area (kp/cm2)
    Mean (median)2.1 (1.9)2.0 (1.9)2.0 (1.7)
    SD1.121.000.93
    Q1; Q31.4; 2.61.3; 2.71.4; 2.6
Tenderness contralateral area (kp/cm2)
    Mean (median)4.7 (4.7)4.9 (5.0)4.5 (4.3)
    SD1.451.651.48
    Q1; Q33.5; 5.73.6; 6.03.6; 5.4
Ratio of tenderness values* (%)
    Mean (median)44.3 (44.4)40.2 (39.7)43.5 (45.3)
    SD13.8014.0912.60
    Q1; Q334.0; 53.328.3; 51.333.3; 51.5
VAS (cm)
    Mean (median)2.8 (2.6)3.3 (2.7)3.3 (3.2)
    SD1.862.632.11
    Q1; Q31.4; 4.10.9; 5.11.3; 4.9
Sprains†
    n (%)4 (7.4)7 (13.7)7 (13.7)
Strains†
    n (%)15 (27.8)15 (29.4)9 (17.6)
Contusions†
    n (%)36 (66.7)30 (58.8)36 (70.6)